Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disorder. Between 85% and 90% of cases result from variations in the PKD1 and PKD2 genes. Over 30 genes have been associated with ADPKD, contributing to its heterogeneity. This study aimed to investigate nov...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2547306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849222175102337024 |
|---|---|
| author | Hande Aypek Rumeysa Fatma Balaban Nuseybe Huriyet Ebrucan Bulut Gulsah Cecener Suat Akgur Orhan Gorukmez Ufuk Unal Guven Ozkaya Alparslan Ersoy Aysegul Oruc Cuma Bulent Gul Abdulmecit Yildiz |
| author_facet | Hande Aypek Rumeysa Fatma Balaban Nuseybe Huriyet Ebrucan Bulut Gulsah Cecener Suat Akgur Orhan Gorukmez Ufuk Unal Guven Ozkaya Alparslan Ersoy Aysegul Oruc Cuma Bulent Gul Abdulmecit Yildiz |
| author_sort | Hande Aypek |
| collection | DOAJ |
| description | Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disorder. Between 85% and 90% of cases result from variations in the PKD1 and PKD2 genes. Over 30 genes have been associated with ADPKD, contributing to its heterogeneity. This study aimed to investigate novel variations in the PKD1, PKD2, and ADPKD-related genes through whole-exome sequencing (WES) and combine the genotype and phenotype data of the patients. WES was performed on peripheral blood samples from 44 ADPKD patients, and variations were evaluated and classified based on ACMG criteria. A heterozygous pathogenic/likely pathogenic (P/LP) PKD1 variant was identified in 33 patients (75%). Seven patients had a heterozygous P/LP PKD2 variant (15.9%). No heterozygous P/LP PKD1 or PKD2 variant was found in 4 patients (9.1%), and one of them (2.3%) had a heterozygous pathogenic PKHD1 variant. Thirteen novel PKD1 variations were identified, with nine associated with fast estimated glomerular filtration rate (eGFR) decline. Potentially pathogenic Variants of Uncertain Significance in ALG9, CEP290, NPHP4, WDR19, and TTC21B were identified in three patients lacking PKD1/PKD2 variants. Survival analysis indicated that patients with PKD1 or PKD2 or without any PKD1/PKD2 mutations experienced a similar age of onset for end-stage kidney disease. The annual decline in eGFR was significantly higher in patients with a PKD1 mutation than in those with a PKD2 mutation, along with a higher Mayo Class. Genetic studies evaluating novel variants in the PKD1, PKD2, and ADPKD-related genes alongside patients’ clinical data are essential for a deeper understanding of ADPKD diagnosis, prognosis, and pathology. |
| format | Article |
| id | doaj-art-3cc52a6ccef44d99ad5cb7daec94d91c |
| institution | Kabale University |
| issn | 0886-022X 1525-6049 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj-art-3cc52a6ccef44d99ad5cb7daec94d91c2025-08-26T07:19:19ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492025-12-0147110.1080/0886022X.2025.2547306Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysisHande Aypek0Rumeysa Fatma Balaban1Nuseybe Huriyet2Ebrucan Bulut3Gulsah Cecener4Suat Akgur5Orhan Gorukmez6Ufuk Unal7Guven Ozkaya8Alparslan Ersoy9Aysegul Oruc10Cuma Bulent Gul11Abdulmecit Yildiz12Division of Nephrology, Bursa Uludag University School of Medicine, Bursa, TürkiyeDepartment of Medical Biology, Bursa Uludag University Faculty of Medicine, Bursa, TürkiyeDepartment of Medical Biology, Bursa Uludag University Faculty of Medicine, Bursa, TürkiyeDepartment of Medical Biology, Bursa Uludag University Faculty of Medicine, Bursa, TürkiyeDepartment of Medical Biology, Bursa Uludag University Faculty of Medicine, Bursa, TürkiyeDivision of Nephrology, Bursa Uludag University School of Medicine, Bursa, TürkiyeDepartment of Medical Genetics, Bursa Yüksek İhtisas Training and Research Hospital, Bursa, TürkiyeDepartment of Medical Biology, Bursa Uludag University Faculty of Medicine, Bursa, TürkiyeDepartment of Biostatistics, Bursa Uludag University Faculty of Medicine, Bursa, TürkiyeDivision of Nephrology, Bursa Uludag University School of Medicine, Bursa, TürkiyeDivision of Nephrology, Bursa Uludag University School of Medicine, Bursa, TürkiyeDivision of Nephrology, Bursa Uludag University School of Medicine, Bursa, TürkiyeDivision of Nephrology, Bursa Uludag University School of Medicine, Bursa, TürkiyeAutosomal dominant polycystic kidney disease (ADPKD) is the most prevalent hereditary kidney disorder. Between 85% and 90% of cases result from variations in the PKD1 and PKD2 genes. Over 30 genes have been associated with ADPKD, contributing to its heterogeneity. This study aimed to investigate novel variations in the PKD1, PKD2, and ADPKD-related genes through whole-exome sequencing (WES) and combine the genotype and phenotype data of the patients. WES was performed on peripheral blood samples from 44 ADPKD patients, and variations were evaluated and classified based on ACMG criteria. A heterozygous pathogenic/likely pathogenic (P/LP) PKD1 variant was identified in 33 patients (75%). Seven patients had a heterozygous P/LP PKD2 variant (15.9%). No heterozygous P/LP PKD1 or PKD2 variant was found in 4 patients (9.1%), and one of them (2.3%) had a heterozygous pathogenic PKHD1 variant. Thirteen novel PKD1 variations were identified, with nine associated with fast estimated glomerular filtration rate (eGFR) decline. Potentially pathogenic Variants of Uncertain Significance in ALG9, CEP290, NPHP4, WDR19, and TTC21B were identified in three patients lacking PKD1/PKD2 variants. Survival analysis indicated that patients with PKD1 or PKD2 or without any PKD1/PKD2 mutations experienced a similar age of onset for end-stage kidney disease. The annual decline in eGFR was significantly higher in patients with a PKD1 mutation than in those with a PKD2 mutation, along with a higher Mayo Class. Genetic studies evaluating novel variants in the PKD1, PKD2, and ADPKD-related genes alongside patients’ clinical data are essential for a deeper understanding of ADPKD diagnosis, prognosis, and pathology.https://www.tandfonline.com/doi/10.1080/0886022X.2025.2547306Autosomal dominant polycystic kidney disease (ADPKD)PKD1PKD2whole exome sequencing (WES) |
| spellingShingle | Hande Aypek Rumeysa Fatma Balaban Nuseybe Huriyet Ebrucan Bulut Gulsah Cecener Suat Akgur Orhan Gorukmez Ufuk Unal Guven Ozkaya Alparslan Ersoy Aysegul Oruc Cuma Bulent Gul Abdulmecit Yildiz Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis Renal Failure Autosomal dominant polycystic kidney disease (ADPKD) PKD1 PKD2 whole exome sequencing (WES) |
| title | Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis |
| title_full | Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis |
| title_fullStr | Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis |
| title_full_unstemmed | Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis |
| title_short | Evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis |
| title_sort | evaluating gene variations in autosomal dominant polycystic kidney disease patients using whole exome sequencing and phenotype to genotype analysis |
| topic | Autosomal dominant polycystic kidney disease (ADPKD) PKD1 PKD2 whole exome sequencing (WES) |
| url | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2547306 |
| work_keys_str_mv | AT handeaypek evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT rumeysafatmabalaban evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT nuseybehuriyet evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT ebrucanbulut evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT gulsahcecener evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT suatakgur evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT orhangorukmez evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT ufukunal evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT guvenozkaya evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT alparslanersoy evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT ayseguloruc evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT cumabulentgul evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis AT abdulmecityildiz evaluatinggenevariationsinautosomaldominantpolycystickidneydiseasepatientsusingwholeexomesequencingandphenotypetogenotypeanalysis |